Vardhaman Laboratories (Delisted) share price
BSE: 524796Pharmaceuticals & Biotechnology
Vardhaman Laboratories Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1995
Last traded ₹0.51 on 16 Aug 2019
Delisted on 13 Jul 2022.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.
Feb 2019
8 Feb · Board meeting
Meeting on 14 Feb 2019: quarterly results
Jan 2019
21 Jan · Shareholding for the Period Ended December 31, 2018
Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click ....21 Jan · Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Nov 2018
Q3 results, quarter to Dec 2018
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
- RevenueRevenue from operations. Money earned from selling the company's goods and services in the period. Revenue from operations in the glossary
- ₹0.00 Cr−100.0% on a year agoChange on a year ago and on the quarter before. The change against the same quarter a year before: (this quarter's figure less that quarter's) divided by that quarter's, times 100. The change on the quarter before is the same sum against the quarter just before, taken as this quarter's results restate it where the company restated it: this quarter's year to date less this quarter. Left out where either figure is a loss, where the restatement covers two or more earlier quarters without saying which, or across a change of basis named under the table, on the lines it affects.
- Operating profitOperating profit before depreciation (EBITDA). Revenue less operating expenses: what the business earns from its operations before depreciation, interest and tax. Operating profit before depreciation (EBITDA) in the glossary
- −₹0.01 Cr
- Net profitNet profit. What is left of revenue and other income after every cost, interest and tax. Net profit in the glossary
- −₹0.01 Cr
- Earnings per shareEarnings per share. Profit belonging to shareholders divided by the number of shares, restated for later splits and bonuses so they do not break the line. Earnings per share in the glossary
- −₹0.02
From revenue to net profit, ₹ crore
- Revenue0.0
- Employee costs0.0
- Other expenses0.0
- Operating profit0.0
- Depreciation0.0
- Other income0.0
- Finance costs0.0
- Profit before tax0.0
- Tax0.0
- Net profit0.0
Vardhaman Laboratories results by quarter
Standalone: the listed company alone, without its subsidiaries. Latest quarter to Dec 2018. Results for the quarter to Mar 2019 were due by 30 May 2019, 60 days after it ends. Every company's dates are on the results calendar.
Revenue and net profit by quarter, ₹ crore
- Revenue
- Net profit
- Loss
Peak revenue ₹0.04 Cr, quarter to Mar 2017; lowest ₹0.00 Cr, quarter to Jun 2018A loss in 11 of the 12 quarters shown
Operating and net margin by quarter, per cent
- Operating margin
- Net margin
| ₹ crore | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018Q1 | Sep 2018 | Dec 2018Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | – | – | – | – | – | – | – | – | – | – | – | – | 0.04 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Operating expenses. What the business spent to run itself in the period, materials, staff and other costs, before depreciation, interest and tax. Operating expenses in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00 | 0.01 | 0.01 |
| Materials and goods boughtCost of materials and goods. Raw materials used and goods bought for resale in the period, adjusted for the change in stock held. Cost of materials and goods in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 |
| Employee costsEmployee costs. Salaries, wages, bonuses and other benefits paid to staff in the period. Employee costs in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 |
| Other expensesOther expenses. Every operating cost besides materials and staff: power, rent, freight, repairs, marketing and the like. Other expenses in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00 | 0.01 | 0.01 |
| Operating profit before depreciation | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00 | −0.01 | −0.01 |
| Depreciation and amortisationDepreciation and amortisation. The part of the cost of plant, buildings and other long-lived assets charged against each year they are used. Depreciation and amortisation in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 |
| Other incomeOther income. Income from outside the main business, such as interest on deposits, dividends received and gains on investments. Other income in the glossary | 0.01 | – | 0.01 | 0.01 | – | 0.01 | – | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Finance costsFinance costs. Interest and the other costs of borrowing in the period. Finance costs in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 |
| One-off itemsExceptional items. Gains or losses the company reports separately because they are not expected to recur, such as selling a business or writing down an asset. Exceptional items in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.00 | −0.02 | 0.00 | −0.01 | – | 0.00 | – | −0.02 | −0.02 | 0.00 | −0.02 | −0.01 | −0.04 | −0.03 | 0.00 | 0.00 | −0.01 | 0.00 | −0.01 | −0.01 |
| Tax | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 |
| Net profit | 0.00 | −0.02 | 0.00 | −0.01 | – | 0.00 | – | −0.02 | −0.02 | 0.00 | −0.02 | −0.01 | −0.04 | −0.03 | 0.00 | 0.00 | −0.01 | 0.00 | −0.01 | −0.01 |
| Net margin | – | – | – | – | – | – | – | – | – | – | – | – | −100.0% | −325.0% | −33.3% | 27.3% | −133.3% | – | – | – |
| Earnings per share | −₹0.01 | – | – | – | – | – | – | – | −₹0.04 | −₹0.01 | −₹0.04 | −₹0.02 | −₹0.09 | −₹0.06 | −₹0.01 | – | −₹0.02 | −₹0.01 | −₹0.01 | −₹0.02 |
Earnings per share in rupees, restated for later splits and bonuses. No results on record for the quarters to Mar 2015 and Sep 2015.
10 years at a glance
Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.
Revenue, net profit and borrowings, ₹ crore
- Revenue
- Net profit
- Borrowings
- Loss
Peak revenue ₹1.22 Cr, year to Mar 2011; lowest ₹0.04 Cr, year to Mar 2018A loss in 7 of the 8 years with results on record
Operating and net margin, per cent
- Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs. Operating margin in the glossary
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
Results for the year to Mar 2018
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
From revenue to net profit
- Revenue0.0
- Other income0.0
- Profit before tax0.0
- Net profit0.0
Profit and loss
Standalone, ₹ crore, years to March. No results on record for the years to Mar 2009 and Mar 2015. The last column is the twelve months to Dec 2018, the latest four quarters added.
| ₹ crore | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Dec 2018Twelve months |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 0.27 | 1.22 | 0.53 | – | – | – | – | 0.04 | 0.04 | 0.01 |
| 0.44 | 1.15 | – | – | – | – | – | – | – | – | |
| Materials and goods bought | – | 1.01 | 0.51 | – | – | – | – | – | – | – |
| Employee costs | – | 0.10 | – | – | – | – | – | – | – | – |
| Other expenses | – | 0.11 | – | – | – | – | – | – | – | – |
| Operating profit before depreciation | −0.16 | 0.06 | – | – | – | – | – | – | – | – |
| Operating margin | −60.6% | 5.0% | – | – | – | – | – | – | – | – |
| Materials, % of revenueMaterials, % of revenue. Raw materials used and goods bought for resale, adjusted for the change in stock, divided by revenue, times 100. Materials, % of revenue in the glossary | – | 83.1% | – | – | – | – | – | – | – | – |
| Employee costs, % of revenueEmployee costs, % of revenue. Salaries, wages and other staff costs divided by revenue, times 100. Employee costs, % of revenue in the glossary | – | 8.3% | – | – | – | – | – | – | – | – |
| Other expenses, % of revenueOther expenses, % of revenue. Operating costs besides materials and staff divided by revenue, times 100; with the two above and the operating margin it makes 100. Other expenses, % of revenue in the glossary | – | 9.1% | – | – | – | – | – | – | – | – |
| Depreciation and amortisation | 0.08 | 0.08 | – | – | – | – | – | – | – | – |
| Operating profit after depreciationOperating profit after depreciation (EBIT). Operating profit before depreciation, less depreciation and amortisation. Operating profit after depreciation (EBIT) in the glossary | −0.24 | −0.02 | – | – | – | – | – | – | – | – |
| Other income | 0.02 | 0.03 | 0.06 | 0.01 | 0.02 | – | 0.05 | 0.04 | 0.04 | 0.01 |
| Finance costs | 0.00 | 0.08 | – | – | – | – | – | – | – | – |
| Profit before tax | −0.23 | −0.14 | −0.02 | −0.02 | −0.02 | – | −0.03 | −0.04 | −0.04 | −0.02 |
| Tax | – | – | – | 0.06 | – | – | – | – | – | – |
| Net profit | −0.23 | −0.14 | 0.27 | −0.10 | −0.02 | – | −0.03 | −0.04 | −0.04 | −0.02 |
| Net margin | −86.3% | −11.2% | 51.5% | – | – | – | – | −100.0% | −105.7% | – |
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2010 they do not, so they are left blank. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2012, Mar 2017 and Mar 2018: the statement does not state its finance costs or depreciation, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2013, Mar 2014 and Mar 2016: the statement does not state its revenue, finance costs or depreciation, which operating profit is worked out from, so operating profit is not given.
Ratios
Standalone, years to March.
| Ratio | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue growthRevenue growth. This year's revenue less last year's, divided by last year's, times 100; blank where last year's is not above nought. Revenue growth in the glossary | 348.3% | −56.2% | – | – | – | – | – | −5.4% |
Interest cover is left blank for the years to Mar 2010 and Mar 2011: operating profit after depreciation is a loss, and a loss covers no interest bill.
Growth and returns over 3, 5 and 10 years
Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2018.
| Measure | 10 years | 5 years | 3 years |
|---|---|---|---|
| Revenue growth, yearly rateRevenue growth, yearly rate. 3 years: Revenue in the latest year ÷ revenue in the year three years before, to the power of one third, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 5 years: Revenue in the latest year ÷ revenue in the year five years before, to the power of one fifth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. 10 years: Revenue in the latest year ÷ revenue in the year ten years before, to the power of one tenth, − 1, × 100: the yearly rate it grew at; empty where either year is missing, nought or a loss, or a change of year end falls between them. | −23.3% | – | – |
| Net margin, averageNet margin, average. 3 years: The plain average of the yearly net profit margin over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly net profit margin over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly net profit margin over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | – | – | −102.9% |
Business segments
In the quarter to Dec 2018 the company reports one business segment, Pharmaceuticals, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2018, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −4.3% | – | – | 0.0% |
| 3 years | −23.1% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Vardhaman Laboratories share price by year
Each calendar year to 2019.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2019 | 0.51 | −22.7% | 0.66 | 0.49 |
| 2018 | 0.66 | +4.8% | 0.66 | 0.63 |
| 2017 | 0.63 | −12.5% | 0.69 | 0.55 |
| 2016 | 0.72 | −55.3% | 1.77 | 0.68 |
| 2015 | 1.61 | −40.6% | 2.58 | 1.26 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The close is the year's last trade for 2019 (16 Aug 2019), 2018 (27 Mar 2018) and 2016 (6 Dec 2016).
Recent sessions
The 10 trading days to 16 Aug 2019, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 16 Aug 2019 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 2,000 |
| 6 Aug 2019 | 0.49 | 0.49 | 0.49 | 0.49 | 0.49 | 100 |
| 24 Jul 2019 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 300 |
| 11 Jul 2019 | 0.53 | 0.53 | 0.49 | 0.49 | 0.51 | 500 |
| 4 Jun 2019 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 100 |
| 3 May 2019 | 0.49 | 0.49 | 0.49 | 0.49 | 0.49 | 100 |
| 24 Apr 2019 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 300 |
| 18 Apr 2019 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 500 |
| 16 Apr 2019 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | 100 |
| 15 Apr 2019 | 0.60 | 0.60 | 0.57 | 0.57 | 0.59 | 700 |
Prices in ₹ per share as traded, not adjusted.
Company details
- BSE code
- 524796
- ISIN
- INE503F01014
- Industry
- Pharmaceuticals & Biotechnology
- CIN
- L85195PN1985PLC036017
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1985
- Registered office
- 1393, High School Road, Post Box No 184, Peth Bhag, Sangli 416416, Maharashtra
- Share registrar
- Link Intime India Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments